VivoSim Labs, Inc. (VIVS)
NASDAQ: VIVS · Real-Time Price · USD
1.860
+0.050 (2.76%)
At close: Jul 17, 2025, 4:00 PM
1.860
0.00 (0.00%)
Pre-market: Jul 18, 2025, 4:51 AM EDT

VivoSim Labs Revenue

In the fiscal year ending March 31, 2025, VivoSim Labs had annual revenue of $144.00K with 32.11% growth. VivoSim Labs had revenue of $51.00K in the quarter ending March 31, 2025, with 75.86% growth.

Revenue (ttm)
$144.00K
Revenue Growth
+32.11%
P/S Ratio
18.91
Revenue / Employee
$11,077
Employees
13
Market Cap
4.84M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2025144.00K35.00K32.11%
Mar 31, 2024109.00K-261.00K-70.54%
Mar 31, 2023370.00K-1.13M-75.33%
Mar 31, 20221.50M--
Mar 31, 2021---
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group410.06B
Johnson & Johnson90.63B
Merck & Co.63.92B
AbbVie57.37B
AstraZeneca54.98B
Novartis AG53.22B
Eli Lilly and Company49.00B
Novo Nordisk43.92B
Revenue Rankings